Used as a key intermediate in the synthesis of thienopyridine-based pharmaceuticals, particularly in the development of anticoagulant drugs that inhibit platelet aggregation. Its structure supports the formation of active metabolites responsible for blocking P2Y12 receptors on platelets, making it valuable in cardiovascular treatments. Also employed in research for optimizing drug stability and bioavailability in oral formulations.